The groundbreaking treatment of the medication represents a exciting advance in the management of the condition. Different to existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide253019.theisblog.com/42443804/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment